Follicle Stimulating Hormone: Clinical Trials

23 trials of Follicle Stimulating Hormone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 6 unknown, 2 not yet recruiting, 2 terminated. 5 Not applicable, 5 Phase 3, 4 Phase 2, 3 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5Unknown 3, Completed 2
Phase 35Completed 3, Suspended 1, Withdrawn 1
Phase 24Terminated 2, Completed 1, Unknown 1
Phase 13Completed 1, Recruiting 1, Unknown 1
Phase 43Not yet recruiting 1, Unknown 1, Withdrawn 1
Early Phase 11Completed 1

Follow Follicle Stimulating Hormone: new trials by email Literature Review of Follicle Stimulating Hormone trials Research Report on Follicle Stimulating Hormone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinician-Selected FSH Starting Dose and Mature Oocyte Yield in Predicted Poor Responders
Follicle-stimulating hormone (FSH) - Infertility, Female, Poor Ovarian Response
Not yet recruitingAmerican Hospital 2 Kosovo1602026-11-012026-11-18
Comparative Efficacy of Antioxidants Alone Versus Combined Therapy With SERMs or FSH in Normogonadotropic Idiopathic OAT Patients: A Randomized Controlled Trial
Antioxidants + Clomiphene Citrate, Antioxidants + FSH, Antioxidants Alone - Oligoasthenoteratozoospermia, Male Infertility
Phase 4Not yet recruitingHamad Medical Corporation3602026-10-152026-10-07
150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial
Follicle-stimulating hormone (FSH) - Infertility, Female
Phase 3WithdrawnAmerican Hospital 2 Kosovo2026-03-012026-10-29
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
Follicle Stimulating Hormone - Infertility, Obesity
Phase 1RecruitingUniversity of Colorado, Denver602024-10-012026-10-14
Effects of FSH on Endothelial Function (FEND)
Follicle Stimulating Hormone - Change in Flow Mediated Dilation
Phase 4UnknownFederico II University162020-07-012020-06-12
Step Down FSH Approach and Late Follicular Phase in Progesterone Level
follicle stimulating hormone - Progesterone Resistance
Early Phase 1CompletedART Fertility Clinics LLC1272017-11-232020-09-09
Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease
Anti Mueller hormone, Estrogen, Follicle-Stimulating Hormone - Fertility Disorders, Ovarian Reserve Function
Not applicableUnknownSixth Affiliated Hospital, Sun Yat-sen University802017-05-012017-09-01
The Safety and Pharmacokinetics of Primapur and Gonal-f
Follitropin alfa (Primapur), Follitropin alfa (Gonal-F) - Area Under Curve, Pharmacokinetics
Phase 1CompletedIVFarma LLC282015-10-292019-08-13
AMH and Dosing Regimens for Initial IVF Stimulation Protocols
300IU Gonal-F, 150IU Menopur, 225IU Gonal-F - Infertility
Not applicableCompletedReproductive Specialists of New York782015-10-222018-04-12
In Vitro Maturation of Human Eggs
IVM media, Follicle Stimulating Hormone (FSH) - Infertility, Reproductive Techniques, Assisted
Not applicableUnknownNational Foundation for Fertility Research1002015-07-012020-05-15
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
follicle stimulating hormone - Sterility
Phase 3SuspendedMedical University of Vienna1652015-05-012015-05-05
FSH in Azoospermic Men
Follicle Stimulating Hormone - Male Infertility
Phase 4WithdrawnAzienda Sanitaria Locale Bari2015-02-012026-10-29
Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
Human Growth Hormone, Follicle Stimulating Hormone - Female Infertility Due to Diminished Ovarian Reserve
Phase 1 / Phase 2UnknownCenter for Human Reproduction302014-08-012020-02-18
Mother-caregivers of Children With Duchenne Muscular Dystrophy
sleep parameters, Hormonal profile, Inflammatory profile - Other Diseases or Conditions
Not applicableCompletedMonica Levy Andersen602013-08-012016-02-03
Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
COL-1620, Gonadotropin-releasing hormone (GnRH) analogue, Follicle-stimulating hormone (FSH) - Luteal Hormone Supplementation in In-vitro Fertilization, Embryo Transfer
Phase 3CompletedMerck KGaA, Darmstadt, Germany1782013-07-012015-12-21
Predicting Ovarian Response in Artificial Insemination With Low Stimulation
Follicle Stimulating Hormone - Subfertility
UnknownIsala5102012-12-012012-12-13
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
Letrozole (aromatase inhibitor), Clomiphene Citrate, Follicle Stimulating Hormone (gonadotropin) - Pregnancy, Unexplained Infertility
Phase 3CompletedYale University9002010-06-012015-02-02
AS900672-Enriched in Ovulation Induction
AS900672-Enriched 10 microgram (mcg), AS900672-Enriched 20 mcg, AS900672-Enriched 30 mcg - Ovulation Induction
Phase 2TerminatedMerck KGaA, Darmstadt, Germany712007-12-012014-02-13
Inactive FSH in Galactosemia
follitropin and lutropin - Galactosemia, Premature Ovarian Failure
Not applicableUnknownMaastricht University Medical Center252007-03-012010-01-12
Second Laparoscopic Surgery for Recurrent Unilateral Endometriomas.
Anti-mullerian hormone (AMH) level dosage., Follicle-stimulating hormone (FSH) level dosage., Antral follicle count (AFC). - Endometrioma, Endometriosis
CompletedIRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy362007-01-012014-11-25

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Infertility (10)  ·  Infertility, Female (2)  ·  Infertility, Male (2)  ·  Primary Ovarian Insufficiency (2)  ·  Atherosclerosis (1)  ·  Endometriosis (1)  ·  Galactosemias (1)  ·  Helping Behavior (1)  ·  Hypogonadism (1)  ·  Kallmann Syndrome (1)  ·  Muscular Dystrophy, Duchenne (1)  ·  Obesity (1)  ·  Oligospermia (1)  ·  Progesterone Resistance (1)

Sponsors

Merck KGaA, Darmstadt, Germany (3)  ·  American Hospital 2 Kosovo (2)  ·  ART Fertility Clinics LLC (1)  ·  Azienda Sanitaria Locale Bari (1)  ·  Center for Human Reproduction (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Federico II University (1)  ·  Hamad Medical Corporation (1)  ·  IBSA Institut Biochimique SA (1)  ·  IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy (1)  ·  IVFarma LLC (1)  ·  Isala (1)  ·  Maastricht University Medical Center (1)  ·  Medical University of Vienna (1)  ·  Monica Levy Andersen (1)

Countries

United States (6)  ·  Italy (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Brazil (1)  ·  China (1)  ·  France (1)  ·  Hungary (1)  ·  Japan (1)  ·  Kosovo (1)  ·  Qatar (1)  ·  Russia (1)  ·  Switzerland (1)  ·  United Arab Emirates (1)

Top investigators

Nanette Santoro, MD (2)  ·  Antonio Pellicer, Professor Dr (1)  ·  Ben Cohlen, dr. (1)  ·  Christos Coutifaris, MD (1)  ·  David H Barad, MD (1)  ·  Estela Rubio-Gozalbo, MD, PhD (1)  ·  Esther Eisenberg, MD, MPH (1)  ·  Gregory Christman, MD (1)  ·  Heping Zhang, PhD (1)  ·  Human Fatemi (1)  ·  Ivan G Gordeev, D.Sc., MD (1)  ·  J G Grudzinskas, Prof (1)  ·  Johannes C. Huber, MD, PhD (1)  ·  Linda Sung, MD (1)

Results publications

PMID 24037890, PMID 25681854, PMID 25707331, PMID 26354094, PMID 26398071, PMID 26413816, PMID 26949110, PMID 27402910, PMID 28089575, PMID 29102040, PMID 29767754, PMID 29778387, PMID 30085176, PMID 30085177, PMID 30982604, PMID 32192596, PMID 32883514, PMID 32972733, PMID 33190149, PMID 33927696, PMID 34180998, PMID 34808697, PMID 35125179, PMID 35386508, PMID 35460412, PMID 38204957, PMID 39672366

NIH funding

U10HD039005 (1), U10HD055925 (1), U54HD028138 (1)